2Scartozzi M ,Faloppi L,Bianconi M ,et al. The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE:impli- cations for clinical management[J]. P LoS One, 2012,7 (3) : e32653.
3Gurkan S,Scarponi KJ,Hotchkiss H,et al. Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia[J]. Pediatr Nephrol, 2010,25 (10) : 2123-2137.
4Jaswal TS, Mehta HC ,Gupta V,et al. Serum lactate dehydrogenase in di- agnosis of megaloblastic anaemia[J]. Indian J Pathol Microbio1,2000,43 (3) :325-329.
5Andros E,Serraj K. Optimal management of pernicious anemia[J]. J Blood Med ,2012,3:97-103.
6Khanduri U,Sharma A. Megaloblastic ana6mia: prevalence and causative faetom[J]. Natl Med J India,2007,20(4):172-175.
7Annibale B,Lahner E,Fave GD. Diagnosis and management of perni- cious anemia[J]. Curr Gastroenterol Rep,2011,13(6) :518-524.
8Ni J,Mei M,Sun L. Oxidative DNA damage and repair in chronic atroph- ic gastritis and gastric cancer[J]. Hepatogastroenterology,2012,59 ( 115 ) : 671-675.
